COVID-19 Koenfeksiyonları: Viral Etkenler

Du Y, Wang C, Zhang Y. Viral coinfections. Viruses 2022; 14(12):2645. doi: 10.3390/v14122645.

Kumar N, Sharma S, Barua S, et al. Virological and immunological outcomes of coinfections. Clinical Microbiology Reviews 2018;31(4):e00111-17. doi: 10.1128/CMR.00111-17.

Essaidi-Laziosi, M., Geiser, J., Huang, S. et al. Interferon-dependent and respiratory virus-specific interference in dual infections of airway epithelia. Scientific Reports 2020; 10:10246. https://doi.org/10.1038/s41598-020-66748-6.

Cheng X, Uchida T, Xia Y, et al. Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection. The Journal of Clinical Investigation 2020;130(6):3205-3220. doi: 10.1172/JCI135616.

Goto H, Ihira H, Morishita K, et al. Enhanced growth of influenza A virus by coinfection with human parainfluenza virus type 2. Medical Microbiology and Immunology 2016;205(3):209-218. doi: 10.1007/s00430-015-0441-y.

Bellecave P, Gouttenoire J, Gajer M, et al. Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference. Hepatology 2009;50(1):46-55. doi: 10.1002/hep.22951.

Goka EA, Vallely PJ, Mutton KJ, et al. Single, dual and multiple respiratory virus infections and risk of hospitalization and mortality. Epidemiology and Infection 2015;143(1):37-47. doi: 10.1017/S0950268814000302.

Shannon KL, Osula VO, Shaw-Saliba K, et al. Emergency Department National Influenza Network Investigators. Viral co-infections are associated with increased rates of hospitalization in those with influenza. Influenza and Other Respiratory Viruses 2022;16(4):780-788. doi: 10.1111/irv.12967.

Mavilia MG, Wu GY. HBV-HCV Coinfection: Viral interactions, management, and viral reactivation. Journal of Clinical and Translational Hepatology 2018;6(3):296-305. doi: 10.14218/JCTH.2018.00016.

Harapan H, Michie A, Sasmono RT, et al. Dengue: A Minireview. Viruses 2020;12(8):829. doi: 10.3390/v12080829.

González-Candelas F, López-Labrador FX, Bracho MA. Recombination in hepatitis C virus. Viruses 2011;3(10):2006-2024. doi: 10.3390/v3102006.

Urbaniak K, Markowska-Daniel I. In vivo reassortment of influenza viruses. Acta Biochimica Polonica 2014;61(3):427-431.

Hoque MN, Akter S, Mishu ID, et al. Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis. Microbial Pathogenesis 2021;156:104941. doi: 10.1016/j.micpath.2021.104941.

Cimolai N. The complexity of co-Infections in the era of COVID-19. SN Comprehensive Clinical Medicine 2021;3(7):1502-1514. doi: 10.1007/s42399-021-00913-4.

Aghbash PS, Eslami N, Shirvaliloo M, et al. Viral coinfections in COVID-19. Journal of Medical Virology 2021;93(9):5310-5322. doi: 10.1002/jmv.27102.

Swets MC, Russell CD, Harrison EM, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet 2022;399(10334):1463-1464. doi: 10.1016/S0140-6736(22)00383-X.

Alhumaid S, Alabdulqader M, Al Dossary N, et al. Global coinfections with bacteria, fungi, and respiratory viruses in children with SARS-CoV-2: A Systematic review and meta-Analysis. Tropical Medicine and Infectious Disease 2022;7(11):380. doi: 10.3390/tropicalmed7110380.

Cong B, Deng S, Wang X, Li Y. The role of respiratory co-infection with influenza or respiratory syncytial virus in the clinical severity of COVID-19 patients: A systematic review and meta-analysis. Journal of Global Health 2022;12:05040. doi: 10.7189/jogh.12.05040.

Wishaupt JO, van der Ploeg T, de Groot R, et al. Single- and multiple viral respiratory infections in children: disease and management cannot be related to a specific pathogen. BMC Infectios Diseases 2017; 17(1):62.

Lansbury L, Lim B, Baskaran V, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. Journal of Infection 2020; 81(2):266-275. doi: 10.1016/j.jinf.2020.05.046.

Zandi M, Soltani S, Fani M, et al. Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children. Osong Public Health and Research Perspectives 2021;12(5):286-292. doi: 10.24171/j.phrp.2021.0140.

Krumbein H, Kümmel LS, Fragkou PC, et al. Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis. Reviewes in Medical Virology 2023;33(1):e2365. doi: 10.1002/rmv.2365.

Trifonova I, Christova I, Madzharova I, et al. Clinical significance and role of coinfections with respiratory pathogens among individuals with confirmed severe acute respiratory syndrome coronavirus-2 infection. Frontiers in Public Health 2022;10:959319. doi: 10.3389/fpubh.2022.959319.

Alosaimi B, Naeem A, Hamed ME, et al. Influenza co-infection associated with severity and mortality in COVID-19 patients. Virology Journal 2021;18(1):127. doi: 10.1186/s12985-021-01594-0.

Bai L, Zhao Y, Dong J, et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Research. 2021;31(4):395-403. doi: 10.1038/s41422-021-00473-1.

Dadashi M, Khaleghnejad S, Abedi Elkhichi P, et al. COVID-19 and influenza co-infection: A systematic review and meta-analysis. Frontiers in Medicine (Lausanne) 2021;8:681469. doi: 10.3389/fmed.2021.681469.

Chotpitayasunondh T, Fischer TK, Heraud JM, et al. Influenza and COVID-19: What does co-existence mean? Influenza and Other Respiratory Viruses 2021;15(3):407-412. doi: 10.1111/irv.12824.

Guan Z, Chen C, Li Y, et al. Impact of coinfection with SARS-CoV-2 and influenza on disease severity: A systematic review and meta-analysis. Frontiers in Public Health 2021;9:773130. doi: 10.3389/fpubh.2021.773130.

Qiu S, Zeng G, Li P, et al. Pneumonia patients caused by co-infection with SARS-CoV-2 and human adenovirus in China. Frontiers in Medicine (Lausanne) 2021;8:735779. doi: 10.3389/fmed.2021.735779.

Gesesew HA, Mwanri L, Stephens JH, et al. COVID/HIV Co-infection: A syndemic perspective on what to ask and how to answer. Frontiers in Public Health 2021;9:623468. doi: 10.3389/fpubh.2021.623468.

Kanwugu ON, Adadi P. HIV/SARS-CoV-2 coinfection: A global perspective. Journal of Medical Virology 2021;93(2):726-732. doi: 10.1002/jmv.26321.

Barbera LK, Kamis KF, Rowan SE, et al. HIV and COVID-19: review of clinical course and outcomes. HIV Research and Clinical Practice 2021;22(4):102-118.doi: 10.1080/25787489.2021.1975608.

CDC. What to know about HIV and COVID-19. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/need-extra precautions/hiv.html. Published 2020. Accessed October 1, 2020.

Suwanwongse K, Shabarek N. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city. Journal of Medical Virology 2020;92(11):2387-2389. doi: 10.1002/jmv.26077.

Gatechompol S, Avihingsanon A, Putcharoen O,et al. COVID-19 and HIV infection co-pandemics and their impact: a review of the literature. AIDS Research and Therapy 2021;18(1):28. doi: 10.1186/s12981-021-00335-1.

Xu L, Liu J, Lu M, et al. Liver injury during highly pathogenic human coronavirus infections. Liver International 2020;40(5):998-1004. doi: 10.1111/liv.14435.

Chen L, Huang S, Yang J, et al. Clinical characteristics in patients with SARS-CoV-2/HBV co-infection. Journal of Viral Hepatitis 2020;27(12):1504-1507. doi: 10.1111/jvh.13362.

Xiang TD, Zheng X. Interaction between hepatitis B virus and SARS-CoV-2 infections. World Journal of Gastroenterology 2021;27(9):782-793. doi: 10.3748/wjg.v27.i9.782.

He YF, Jiang ZG, Wu N, et al. Correlation between COVID-19 and hepatitis B: A systematic review. World Journal of Gastroenterology 2022;28(46):6599-6618. doi: 10.3748/wjg.v28.i46.6599.

Kadambari S, Klenerman P, Pollard AJ. Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV. Reviews in Medical Virology 2020;30(5):e2144. doi: 10.1002/rmv.2144.

Perera MR, Greenwood EJD, Crozier TWM, et al. Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research COVID BioResource Collaboration. Human cytomegalovirus infection of epithelial cells increases SARS-CoV-2 superinfection by upregulating the ACE2 receptor. Journal of Infectious Disease 2023;227(4):543-553. doi: 10.1093/infdis/jiac452.

Carll WC, Rady MY, Salomao MA, et al. Cytomegalovirus haemorrhagic enterocolitis associated with severe infection with COVID-19. BMJ Open Gastroenterology 2021;8(1):e000556. doi: 10.1136/bmjgast-2020-000556.

Molaei H, Khedmat L, Nemati E, et al. Iranian kidney transplant recipients with COVID-19 infection: Clinical outcomes and cytomegalovirus coinfection. Transplant Infectious Disease 2021;23(1):e13455. doi: 10.1111/tid.13455.

Roncati L, Lusenti B, Nasillo V, et al. Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease. Annals of Hematology 2020;99(8):1945-1946. doi: 10.1007/s00277-020-04098-z.

Tsheten T, Clements ACA, Gray DJ, et al. Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review. BMC Infectious Disease 2021;21(1):729. doi: 10.1186/s12879-021-06409-9.

Prapty CNBS, Rahmat R, Araf Y, et al. SARS-CoV-2 and dengue virus co-infection: Epidemiology, pathogenesis, diagnosis, treatment, and management. Reviews of Medical Virology 2023;33(1):e2340. doi: 10.1002/rmv.2340.

Huang YT, Hite S, Duane V, et al. CV-1 and MRC-5 mixed cells for simultaneous detection of herpes simplex viruses and varicella zoster virus in skin lesions. Journal of Clinical Virology 2002;24(1-2):37-43. doi: 10.1016/s1386-6532(01)00230-x.

LaSala PR, Bufton KK, Ismail N, et al. Prospective comparison of R-mix shell vial system with direct antigen tests and conventional cell culture for respiratory virus detection. Journal of Clinical Virology 2007;38(3):210-216. doi: 10.1016/j.jcv.2006.12.015.

Wu W, Tang YW. Emerging molecular assays for detection and characterization of respiratory viruses. Clinics in Laboratory Medicine 2009;29(4):673-693. doi: 10.1016/j.cll.2009.07.005.

Huang HS, Tsai CL, Chang J, et al. Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis. Clinical Microbiology and Infection 2018;24(10):1055-1063. doi: 10.1016/j.cmi.2017.11.018.

Chen EC, Miller SA, DeRisi JL, Chiu CY. Using a pan-viral microarray assay (Virochip) to screen clinical samples for viral pathogens. Journal of Visualized Experiments 2011;(50):2536. doi: 10.3791/2536.

Fayyadh TK, Ma F, Qin C, et al. Simultaneous detection of multiple viruses in their co-infected cells using multicolour imaging with self-assembled quantum dot probes. Mikrochimica Acta 2017;184(8):2815–2824. doi: 10.1007/s00604-017-2300-6.

Peeling RW, Heymann DL, Teo YY, et al. Diagnostics for COVID-19: moving from pandemic response to control. Lancet 2022;399(10326):757-768. doi: 10.1016/S0140-6736(21)02346-1.

Du Y, Wang C, Zhang Y. Viral coinfections. Viruses 2022; 14(12):2645. doi: 10.3390/v14122645.

Kumar N, Sharma S, Barua S, et al. Virological and immunological outcomes of coinfections. Clinical Microbiology Reviews 2018;31(4):e00111-17. doi: 10.1128/CMR.00111-17.

Essaidi-Laziosi, M., Geiser, J., Huang, S. et al. Interferon-dependent and respiratory virus-specific interference in dual infections of airway epithelia. Scientific Reports 2020; 10:10246. https://doi.org/10.1038/s41598-020-66748-6.

Cheng X, Uchida T, Xia Y, et al. Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection. The Journal of Clinical Investigation 2020;130(6):3205-3220. doi: 10.1172/JCI135616.

Goto H, Ihira H, Morishita K, et al. Enhanced growth of influenza A virus by coinfection with human parainfluenza virus type 2. Medical Microbiology and Immunology 2016;205(3):209-218. doi: 10.1007/s00430-015-0441-y.

Bellecave P, Gouttenoire J, Gajer M, et al. Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference. Hepatology 2009;50(1):46-55. doi: 10.1002/hep.22951.

Goka EA, Vallely PJ, Mutton KJ, et al. Single, dual and multiple respiratory virus infections and risk of hospitalization and mortality. Epidemiology and Infection 2015;143(1):37-47. doi: 10.1017/S0950268814000302.

Shannon KL, Osula VO, Shaw-Saliba K, et al. Emergency Department National Influenza Network Investigators. Viral co-infections are associated with increased rates of hospitalization in those with influenza. Influenza and Other Respiratory Viruses 2022;16(4):780-788. doi: 10.1111/irv.12967.

Mavilia MG, Wu GY. HBV-HCV Coinfection: Viral interactions, management, and viral reactivation. Journal of Clinical and Translational Hepatology 2018;6(3):296-305. doi: 10.14218/JCTH.2018.00016.

Harapan H, Michie A, Sasmono RT, et al. Dengue: A Minireview. Viruses 2020;12(8):829. doi: 10.3390/v12080829.

González-Candelas F, López-Labrador FX, Bracho MA. Recombination in hepatitis C virus. Viruses 2011;3(10):2006-2024. doi: 10.3390/v3102006.

Urbaniak K, Markowska-Daniel I. In vivo reassortment of influenza viruses. Acta Biochimica Polonica 2014;61(3):427-431.

Hoque MN, Akter S, Mishu ID, et al. Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis. Microbial Pathogenesis 2021;156:104941. doi: 10.1016/j.micpath.2021.104941.

Cimolai N. The complexity of co-Infections in the era of COVID-19. SN Comprehensive Clinical Medicine 2021;3(7):1502-1514. doi: 10.1007/s42399-021-00913-4.

Aghbash PS, Eslami N, Shirvaliloo M, et al. Viral coinfections in COVID-19. Journal of Medical Virology 2021;93(9):5310-5322. doi: 10.1002/jmv.27102.

Swets MC, Russell CD, Harrison EM, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet 2022;399(10334):1463-1464. doi: 10.1016/S0140-6736(22)00383-X.

Alhumaid S, Alabdulqader M, Al Dossary N, et al. Global coinfections with bacteria, fungi, and respiratory viruses in children with SARS-CoV-2: A Systematic review and meta-Analysis. Tropical Medicine and Infectious Disease 2022;7(11):380. doi: 10.3390/tropicalmed7110380.

Cong B, Deng S, Wang X, Li Y. The role of respiratory co-infection with influenza or respiratory syncytial virus in the clinical severity of COVID-19 patients: A systematic review and meta-analysis. Journal of Global Health 2022;12:05040. doi: 10.7189/jogh.12.05040.

Wishaupt JO, van der Ploeg T, de Groot R, et al. Single- and multiple viral respiratory infections in children: disease and management cannot be related to a specific pathogen. BMC Infectios Diseases 2017; 17(1):62.

Lansbury L, Lim B, Baskaran V, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. Journal of Infection 2020; 81(2):266-275. doi: 10.1016/j.jinf.2020.05.046.

Zandi M, Soltani S, Fani M, et al. Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children. Osong Public Health and Research Perspectives 2021;12(5):286-292. doi: 10.24171/j.phrp.2021.0140.

Krumbein H, Kümmel LS, Fragkou PC, et al. Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis. Reviewes in Medical Virology 2023;33(1):e2365. doi: 10.1002/rmv.2365.

Trifonova I, Christova I, Madzharova I, et al. Clinical significance and role of coinfections with respiratory pathogens among individuals with confirmed severe acute respiratory syndrome coronavirus-2 infection. Frontiers in Public Health 2022;10:959319. doi: 10.3389/fpubh.2022.959319.

Alosaimi B, Naeem A, Hamed ME, et al. Influenza co-infection associated with severity and mortality in COVID-19 patients. Virology Journal 2021;18(1):127. doi: 10.1186/s12985-021-01594-0.

Bai L, Zhao Y, Dong J, et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Research. 2021;31(4):395-403. doi: 10.1038/s41422-021-00473-1.

Dadashi M, Khaleghnejad S, Abedi Elkhichi P, et al. COVID-19 and influenza co-infection: A systematic review and meta-analysis. Frontiers in Medicine (Lausanne) 2021;8:681469. doi: 10.3389/fmed.2021.681469.

Chotpitayasunondh T, Fischer TK, Heraud JM, et al. Influenza and COVID-19: What does co-existence mean? Influenza and Other Respiratory Viruses 2021;15(3):407-412. doi: 10.1111/irv.12824.

Guan Z, Chen C, Li Y, et al. Impact of coinfection with SARS-CoV-2 and influenza on disease severity: A systematic review and meta-analysis. Frontiers in Public Health 2021;9:773130. doi: 10.3389/fpubh.2021.773130.

Qiu S, Zeng G, Li P, et al. Pneumonia patients caused by co-infection with SARS-CoV-2 and human adenovirus in China. Frontiers in Medicine (Lausanne) 2021;8:735779. doi: 10.3389/fmed.2021.735779.

Gesesew HA, Mwanri L, Stephens JH, et al. COVID/HIV Co-infection: A syndemic perspective on what to ask and how to answer. Frontiers in Public Health 2021;9:623468. doi: 10.3389/fpubh.2021.623468.

Kanwugu ON, Adadi P. HIV/SARS-CoV-2 coinfection: A global perspective. Journal of Medical Virology 2021;93(2):726-732. doi: 10.1002/jmv.26321.

Barbera LK, Kamis KF, Rowan SE, et al. HIV and COVID-19: review of clinical course and outcomes. HIV Research and Clinical Practice 2021;22(4):102-118.doi: 10.1080/25787489.2021.1975608.

CDC. What to know about HIV and COVID-19. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/need-extra precautions/hiv.html. Published 2020. Accessed October 1, 2020.

Suwanwongse K, Shabarek N. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city. Journal of Medical Virology 2020;92(11):2387-2389. doi: 10.1002/jmv.26077.

Gatechompol S, Avihingsanon A, Putcharoen O,et al. COVID-19 and HIV infection co-pandemics and their impact: a review of the literature. AIDS Research and Therapy 2021;18(1):28. doi: 10.1186/s12981-021-00335-1.

Xu L, Liu J, Lu M, et al. Liver injury during highly pathogenic human coronavirus infections. Liver International 2020;40(5):998-1004. doi: 10.1111/liv.14435.

Chen L, Huang S, Yang J, et al. Clinical characteristics in patients with SARS-CoV-2/HBV co-infection. Journal of Viral Hepatitis 2020;27(12):1504-1507. doi: 10.1111/jvh.13362.

Xiang TD, Zheng X. Interaction between hepatitis B virus and SARS-CoV-2 infections. World Journal of Gastroenterology 2021;27(9):782-793. doi: 10.3748/wjg.v27.i9.782.

He YF, Jiang ZG, Wu N, et al. Correlation between COVID-19 and hepatitis B: A systematic review. World Journal of Gastroenterology 2022;28(46):6599-6618. doi: 10.3748/wjg.v28.i46.6599.

Kadambari S, Klenerman P, Pollard AJ. Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV. Reviews in Medical Virology 2020;30(5):e2144. doi: 10.1002/rmv.2144.

Perera MR, Greenwood EJD, Crozier TWM, et al. Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research COVID BioResource Collaboration. Human cytomegalovirus infection of epithelial cells increases SARS-CoV-2 superinfection by upregulating the ACE2 receptor. Journal of Infectious Disease 2023;227(4):543-553. doi: 10.1093/infdis/jiac452.

Carll WC, Rady MY, Salomao MA, et al. Cytomegalovirus haemorrhagic enterocolitis associated with severe infection with COVID-19. BMJ Open Gastroenterology 2021;8(1):e000556. doi: 10.1136/bmjgast-2020-000556.

Molaei H, Khedmat L, Nemati E, et al. Iranian kidney transplant recipients with COVID-19 infection: Clinical outcomes and cytomegalovirus coinfection. Transplant Infectious Disease 2021;23(1):e13455. doi: 10.1111/tid.13455.

Roncati L, Lusenti B, Nasillo V, et al. Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease. Annals of Hematology 2020;99(8):1945-1946. doi: 10.1007/s00277-020-04098-z.

Tsheten T, Clements ACA, Gray DJ, et al. Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review. BMC Infectious Disease 2021;21(1):729. doi: 10.1186/s12879-021-06409-9.

Prapty CNBS, Rahmat R, Araf Y, et al. SARS-CoV-2 and dengue virus co-infection: Epidemiology, pathogenesis, diagnosis, treatment, and management. Reviews of Medical Virology 2023;33(1):e2340. doi: 10.1002/rmv.2340.

Huang YT, Hite S, Duane V, et al. CV-1 and MRC-5 mixed cells for simultaneous detection of herpes simplex viruses and varicella zoster virus in skin lesions. Journal of Clinical Virology 2002;24(1-2):37-43. doi: 10.1016/s1386-6532(01)00230-x.

LaSala PR, Bufton KK, Ismail N, et al. Prospective comparison of R-mix shell vial system with direct antigen tests and conventional cell culture for respiratory virus detection. Journal of Clinical Virology 2007;38(3):210-216. doi: 10.1016/j.jcv.2006.12.015.

Wu W, Tang YW. Emerging molecular assays for detection and characterization of respiratory viruses. Clinics in Laboratory Medicine 2009;29(4):673-693. doi: 10.1016/j.cll.2009.07.005.

Huang HS, Tsai CL, Chang J, et al. Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis. Clinical Microbiology and Infection 2018;24(10):1055-1063. doi: 10.1016/j.cmi.2017.11.018.

Chen EC, Miller SA, DeRisi JL, Chiu CY. Using a pan-viral microarray assay (Virochip) to screen clinical samples for viral pathogens. Journal of Visualized Experiments 2011;(50):2536. doi: 10.3791/2536.

Fayyadh TK, Ma F, Qin C, et al. Simultaneous detection of multiple viruses in their co-infected cells using multicolour imaging with self-assembled quantum dot probes. Mikrochimica Acta 2017;184(8):2815–2824. doi: 10.1007/s00604-017-2300-6.

Peeling RW, Heymann DL, Teo YY, et al. Diagnostics for COVID-19: moving from pandemic response to control. Lancet 2022;399(10326):757-768. doi: 10.1016/S0140-6736(21)02346-1.